Biotech · Private company
Radionetics Oncology
Track this companyFree. Adds Radionetics Oncology to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- 177Lu-R11228Phase 1 · Locoregionally Recurrent Hormone-receptor Positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- 68Ga-R10602 injectionPhase 1 · Locoregionally Recurrent Hormone-receptor Positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- 68Ga-R11228Phase 1 · Locoregionally Recurrent Hormone-receptor Positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- 68Ga-R8760 injectionPhase 1 · Adrenocortical CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- 68Ga-R8760 injection at pre-defined dose levelsPhase 1 · Adrenocortical CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast CancerPHASE1 · TERMINATED · started Oct 1, 2025ClinicalTrials.gov NCT07121244 · fetched Nov 12, 2026
- Study of 68Ga-R10602PHASE1 · COMPLETED · started Dec 10, 2024ClinicalTrials.gov NCT06745804 · fetched Nov 12, 2026
- Phase 1 Study of 68Ga-R8760PHASE1 · TERMINATED · started Sep 11, 2023ClinicalTrials.gov NCT05999292 · fetched Nov 12, 2026